Identification of multispecific organic anion transporter 2 expressed predominantly in the liver  by Sekine, Takashi et al.
Identi¢cation of multispeci¢c organic anion transporter 2 expressed
predominantly in the liver
Takashi Sekinea, Seok Ho Chab, Minoru Tsudaa, Nopporn Apiwattanakula,
Noriko Nakajimaa, Yoshikatsu Kanaia, Hitoshi Endoua;*
aKyorin University School of Medicine, Department of Pharmacology and Toxicology, Mitaka, Tokyo 181, Japan
bDepartment of Pharmacology, Catholic University Medical College, Banpo-dong 505, Seocho-gu, Seoul 137-701, South Korea
Received 3 April 1998; revised version received 8 May 1998
Abstract In the present study, we demonstrate that NLT (novel
liver-specific transport protein) is a multispecific organic anion
transporter of the liver. The amino acid sequence of NLT shows
42% identity to that of the renal multispecific organic anion
transporter, OAT1. When expressed in Xenopus laevis oocytes,
NLT mediated uptake of organic anions, such as salicylate,
acetylsalicylate, PGE2, dicarboxylates and p-aminohippurate.
[14C]Salicylate uptake via NLT was saturable (Km = 88.8 þ 23.4
WM) and sodium-independent. Expression of the mRNA of NLT
was detected in the liver and kidney (liverEkidney). We propose
that NLT be renamed OAT2.
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1. Introduction
The liver and kidney cells take up a number of organic
anions from the plasma across their basolateral membranes
[1^7]. Both similarities and di¡erences exist between the or-
ganic anion transport systems in these two organs. Several
organic anions are transported both by the liver and by the
kidney, such as sulfonamides, L-lactam antibiotics, phenol red
derivatives, steroid hormones and sulfonic acid dyes [8] ; how-
ever, the substrate selectivity of the two systems is not iden-
tical. For example, phenolsulfophthalein and sulfobromoph-
thalein (BSP) are excreted qualitatively into both the urine
and the bile, although the former dye is predominantly ex-
creted in the urine and the latter in bile.
So far two bile acid transporters located on the sinusoidal
membrane of the hepatocytes have been identi¢ed: oatp1 (or-
ganic anion-transporting polypeptide 1) [9] and Ntcp (Na-
taurocholate co-transporter) [10]. Interestingly, oatp1 trans-
ports several organic anions with di¡erent chemical structures,
such as bile acids, BSP, conjugated steroid hormones and
ochratoxin A [9,11^13], and has therefore been regarded as
a multispeci¢c organic anion transporter. However, oatp1
cannot totally account for the diverse organic anion transport
in the liver [14^17].
Recently we isolated a renal organic anion transporter
(OAT1) using the expression cloning method, which trans-
ports a variety of organic anions, including p-aminohippurate
(PAH), various dicarboxylates, cyclic nucleotides, prosta-
noids, urate, L-lactam antibiotics, non-steroidal anti-in£am-
matory drugs and diuretics [18]. Independently, cDNAs en-
coding renal organic anion transporter of winter £ounder
(fROAT) [19] and rat (ROAT1) [20] were isolated. The amino
acid sequence of ROAT1 is 100% identical to that of OAT1,
whereas fROAT shows 46.9% identity to OAT1. OAT1 is the
multispeci¢c organic anion transporter of the basolateral
membrane of the proximal tubule, whose transport properties
have been extensively clari¢ed by numerous physiological and
pharmacological studies [5^7]. OAT1 mediates the elimination
of endogenous and exogenous organic anions from the kid-
ney.
A search of the DNA database revealed that the amino acid
sequence of a liver-speci¢c membrane protein, NLT (novel
liver-speci¢c transport protein), exhibits 42% identity to that
of OAT1. NLT was isolated from a rat liver cDNA library
using a monoclonal antibody against a glucagon receptor and
its expression was limited to the sinusoidal membrane of the
hepatocyte [21]. NLT possesses 12 putative transmembrane
domains with speci¢c transporter motifs and it shows a low
sequence identity to sugar transporters (e.g. GLUT); how-
ever, the substrate(s) of NLT has(ve) not been identi¢ed yet
[21]. Based on the sequence homology with OAT1 and its
characteristic tissue distribution, we hypothesized that NLT
might be a multispeci¢c organic anion transporter of the liver.
In the present study, we demonstrated that NLT mediates
sodium-independent, multispeci¢c organic anion transport
and is exclusively expressed in the liver. NLT is the second
member of the multispeci¢c organic anion transporter family.
2. Materials and methods
2.1. Isolation of NLT
A non-directional cDNA library was constructed from 3 Wg of rat
liver poly(A) RNA using the Superscript Choice system (Life Tech-
nology), and was ligated to a phage vector VZipLox EcoRI arms (Life
Technology). A PCR product corresponding to nucleotides 131^673
of NLT was labeled with 32P-dCTP by random priming (T7 Quick-
Prime Kit, Pharmacia) and used for the screening of a rat liver cDNA
library. Replicated ¢lters of a phage library were hybridized overnight
at 37‡C in a hybridization solution (50% formamide/5Ustandard sal-
ine citrate (SSC)/3UDenhardt’s solution/0.2% SDS/10% dextran sul-
fate/0.3 mg/ml denatured salmon sperm DNA/2.5 mM sodium pyro-
phosphate/25 mM MES/0.03% Antifoam A, pH 6.5). The ¢lters were
washed ¢nally at 37‡C in 0.1USSC/0.1% SDS. Positive cDNA inserts
in VZipLox phage vector were recovered into the plasmid pZL1 by in
vitro excision.
2.2. Sequence of NLT
Specially synthesized oligonucleotide primers were used for se-
quencing of the cDNA obtained by the screening. Sequencing was
performed by the dideoxy termination method.
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2.3. cRNA synthesis and uptake experiment using Xenopus laevis
oocytes
The plasmid DNAs in the pZL were used for in vitro transcription.
Capped cRNAs were synthesized in vitro using T7 RNA polymerase
from the linearized plasmid DNAs with BamHI. Defolliculated oo-
cytes were injected with 10 ng of capped cRNAs and incubated in
Barth’s solution containing gentamicin (88 mM NaCl, 1 mM KCl,
0.33 mM Ca(NO3)2, 0.4 mM CaCl2, 0.8 mM MgSO4, 2.4 mM
NaHCO3, 10 mM HEPES, gentamicin 50 Wg/ml, pH 7.4) at 18‡C.
After incubation for 2^3 days, uptake experiments were performed
in ND96 solution (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM
MgCl2, 5 mM HEPES, pH 7.4) containing radiolabeled substrates, as
indicated in each experiment, at room temperature.
2.4. Northern blot analysis
Three microgram of poly(A) RNA prepared from various rat
tissues was electrophoresed on a 1% agarose/formaldehyde gel and
transferred onto a nitrocellulose ¢lter. The ¢lter was hybridized in a
hybridization solution overnight at 42‡C with a full-length cDNA of
NLT which was randomly labeled with 32P-dCTP. The ¢lter was
washed ¢nally in 0.1USSC/0.1% SDS at 65‡C.
3. Results
3.1. Isolation and sequencing of NLT
Using the 32P-labeled NLT fragment as a probe, we isolated
six positive cDNA clones from the rat liver cDNA library.
Three clones were presumed to contain the total coding region
of NLT, from which we synthesized the cRNAs in vitro.
When expressed in Xenopus laevis oocytes, two of these clones
(clones L1 and L5) mediated the uptake of [14C]K-glutarate.
In the following experiments we further analyzed clone L5.
The nucleotide sequence of L5 is identical to that of NLT
except one base change (G at position 1509 to C) resulting
in the change of an amino acid (Arg479 to Pro). L5 lacks
nucleotides 1^23 of NLT, and contains 13 poly(A).
3.2. Functional characterization
Oocytes injected with L5 cRNA mediated the transport of
[14C]salicylate in a sodium-independent manner (Fig. 1A).
Since the renal multispeci¢c organic anion transporter,
OAT1, is an organic anion/dicarboxylate exchanger [18], we
examined whether dicarboxylic acid trans-stimulates the or-
ganic anion uptake via L5. As previously described [18], we
co-expressed L5 and rat Na-dicarboxylate transporter
(rNaDC-1) in oocytes and performed the uptake experiment.
The uptake rate of [14C]salicylate via L5 was measured after
preincubating the oocytes with 1 mM glutarate, which induces
an outwardly directed dicarboxylate gradient. If L5 was an
organic anion/dicarboxylate exchanger, intracellularly accu-
mulated glutarate, via rNaDC-1, would stimulate the uptake
of [14C]salicylate via L5. As shown in Fig. 1B, the outwardly
directed gradient of glutarate did not enhance the uptake rate
of [14C]salicylate via L5.
As shown in Fig. 2, L5 mediated the transport of several
organic anions with di¡erent chemical structures, such as
[14C]K-ketoglutarate, [3H]prostaglandin E2, [3H]methotrexate
and [14C]acetylsalicylate. L5 also mediated a low level trans-
port of [14C]PAH, which is a prototype substrate for the renal
organic anion transport system. In contrast, L5 did not trans-
port [14C]tetraethylammonium, which is a typical substrate for
the organic cation transport system of the kidney (data not
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Fig. 1. [14C]Salicylate uptake in Xenopus laevis oocytes expressing
L5. A: Independence of L5-mediated [14C]salicylate (10 WM) uptake
of extracellular Na. B: Independence of L5-mediated [14C]salicylate
uptake of intracellular glutarate concentration. Oocytes are ex-
pressed with L5 or L5 and rNaDC-1. 10 WM [14C]salicylate uptake
was determined with or without the preincubation of the oocytes
with 1 mM glutarate.
Fig. 2. L5-mediated uptake of radiolabeled organic anions. The up-
take rates of radiolabeled compounds ([14C]K-ketoglutarate: 7 WM,
[3H]prostaglandin E2 : 6 nM, [3H]methotrexate: 1 WM, [14C]acetyl-
salicylate: 20 WM, [14C]PAH: 20 WM) by control (open column) or
L5-expressed (closed column) oocytes were measured for 1 h
(mean þ S.E.M.; n = 5^8).
T. Sekine et al./FEBS Letters 429 (1998) 179^182180
shown). L5 did not mediate the transport of either cholate,
taurocholate or estrone sulfate (data not shown).
We analyzed the transport kinetics of K-ketoglutarate and
salicylate via L5. Fig. 3 shows the concentration-dependent
uptake of [14C]K-ketoglutarate and [14C]salicylate via L5.
Transport of K-ketoglutarate and salicylate via L5 exhibits
saturable kinetics and follows the Michaelis-Menten equation.
The calculated Km values of K-ketoglutarate and salicylate
were 17.8 þ 2.9 WM and 88.8 þ 23.4 WM, respectively.
In order to further evaluate the substrate speci¢city of L5,
we performed an inhibition study in oocytes expressing L5.
The uptake of 1 WM [14C]salicylate via L5 was determined in
the presence or absence of 1 mM test substrates; the concen-
tration of BSP used was 250 WM because of its cytotoxic
e¡ect. As shown in Fig. 4, BSP, indocyanin green (ICG),
cholic acid, bumetanide, cefoperazone, rifampicin and keto-
profen exerted inhibitory e¡ects on the transport of salicylate
via L5.
3.3. Northern blot analysis
We investigated the tissue distribution of L5 (Fig. 5). High-
stringency Northern blot analysis revealed that mRNA ex-
pression of L5 is liver-speci¢c. A transcript (2.0 kb) was de-
tected strongly in the liver and weakly in the kidney. No
positive signal for the mRNA was detected in other rat tis-
sues, including the testis, small and large intestines, spleen,
brain, eye, placenta or lung.
4. Discussion
Organic anions represent a group of chemically heteroge-
neous compounds which possess a carbon backbone and carry
a net negative charge at physiological pH, and include a large
number of endogenous (e.g. bile acids, bilirubin and fatty
acids) and exogenous substances (anionic drugs, carcinogens,
food additives and environmental toxins). Hepatocytes take
up these organic anions from the plasma and secrete them
into bile [1^4]. Organic anions, besides being transported,
are also actively produced within the liver. Lipophilic com-
pounds which enter hepatocytes by passive di¡usion are sub-
jected to phase I and phase II reactions, resulting in the pro-
duction of various organic anions, which are not only secreted
into bile but also re£uxed into the blood stream. Thus, the
sinusoidal membranes of hepatocytes are continuously in-
volved in the bidirectional transport of organic anions [4].
Recent physiological studies have indicated that the transport
of a large number of organic anions across the sinusoidal
membrane of the hepatocytes is mediated by multispeci¢c or-
ganic anion transporter(s) [1^3].
Bile acids are the major organic anions secreted from the
liver, and undergo enterohepatic circulation [2]. Owing to its
physiological importance, the transport of bile acids in the
liver has been extensively investigated. Recently, two bile
acid transporters have been isolated using the expression clon-
ing method: Ntcp [10] and oatp1 [9]. In contrast to Ntcp
which transports only bile acids, oatp1 has been shown to
be a multispeci¢c transporter. Oatp transports not only bile
acids, but also conjugated steroid hormones, several anionic
dyes (such as BSP) and ochratoxin A [9,11^13]. The diversity
of hepatocellular uptake of organic anions across the sinus-
oidal membrane was therefore attributed to oatp1. However,
it soon became apparent that oatp1 does not mediate the
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Fig. 3. Concentration dependence of L5-mediated uptake of [14C]K-
ketoglutarate and [14C]salicylate.
Fig. 4. Inhibition of L5-mediated [14C]salicylate uptake by various
compounds. The concentration of [14C]salicylate was 1 WM and
those of inhibitors were 1 mM except BSP (250 WM). The values
are expressed as a percentage of L5-mediated [14C]salicylate uptake
without the inhibitor (mean þ S.E.M.; n = 5^8 oocytes).
Fig. 5. Northern blot analysis of L5 in rat tissues. 3 Wg of poly(A)
RNAs from various rat tissues were probed with 32P-labeled cDNA
of L5.
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transport of characteristic substrates of the organic anion
transport system of the sinusoidal membrane of the liver
[16,17]. Oatp1-mediated uptake of BSP was not cis-inhibited
by organic anions such as bumetanide, dicarboxylic acids,
rifampicin, LTC4 and reduced GSH [14]. So far, three iso-
forms of oatp1, that is oatp2 [22], OAT-K1 [23] and prosta-
glandin transporter (PGT) [24], have been isolated. Oatp2
exhibits similar substrate selectivity as oatp1. OAT-K1 and
PGT transport methotrexate and prostaglandins, respectively.
The isoforms of oatp also do not explain the transport of a
variety of organic anions in the liver.
From the observation of the structural similarity of NLT to
the renal multispeci¢c organic anion transporter OAT1, we
investigated the organic anion transport via NLT and dem-
onstrated that NLT mediates multispeci¢c organic anion
transport. The substrate selectivity of NLT and OAT1 ap-
pears similar, however, the transport e⁄cacy of each substrate
is di¡erent. Previous physiological experiments have revealed
that PAH is excreted mainly into the urine and scarcely into
the bile. On the other hand, salicylate is taken up by both the
liver and the kidney. The transport of PAH by NLT occurs at
a much lower level than that by OAT1 [18]; in contrast, the
transport of salicylate by NLT occurs at a higher level than
that by OAT1 (unpublished data). The di¡erent transport
e⁄cacy of NLT and OAT1 may re£ect the di¡erent tissue
distribution of organic anions in the body. For examples, L-
lactam antibiotics are usually excreted into the urine by renal
proximal tubule cells via the organic anion transport path-
way; however, several drugs exist which are excreted mainly
into the bile, e.g. cefoperazone and piperacillin. Nearly all of
the L-lactam antibiotics are very hydrophilic compounds and
their e⁄cient uptake into the liver requires the mediation of
carrier(s). The di¡erence in pharmacokinetics among the L-
lactam antibiotics may be explained by the di¡erent substrate
selectivity and the speci¢c tissue distribution of OAT1 and
NLT. Bumetanide is a diuretic which is taken up by both
the kidney and the liver. It has been reported that bumetanide
is transported not by oatp [17,25], but by the kidney-like
organic anion transport system in the liver. NLT may also
be responsible for the hepatocellular uptake of bumetanide.
Further functional analyses are required for the clari¢cation
of the role of NLT in organic anion transport in the liver.
The transport of organic anions has been demonstrated in
other organs, such as the ciliary body, lung, placenta, choroid
plexus and intestine [5]. Recently the transport of PAH
through the blood-brain barrier was demonstrated [26].
When PAH was microinjected into a cerebral cortex region
termed Par2, it was extensively eliminated from the ipsilateral
cerebrum and this transport of PAH showed a saturation
kinetic with a Michaelis constant of 400 WM. Nonetheless,
the studies of the organic anion transport in these tissues
are limited because of technical di⁄culties. We hypothesized
the existence of other members of the multispeci¢c organic
anion transporter family (OAT family) in these tissues and
have already identi¢ed several. Identi¢cation of all the mem-
bers may help to clarify why certain organic anions are pref-
erentially distributed in certain organ(s).
Salicylate uptake via NLT is sodium-independent like that
via OAT1. In the liver as well as the kidney, the presence of a
dicarboxylate/organic anion exchange system has been pre-
dicted [27]. In the present study however, we could not dem-
onstrate the trans-stimulatory e¡ect of glutarate on the uptake
of salicylate. Although only from this evidence it is di⁄cult to
conclude that NLT is not an exchanger, NLT may function as
a facilitatory transporter rather than an exchanger. Thus the
transport properties of NLT remain to be elucidated.
In conclusion, we demonstrated that the liver-speci¢c trans-
porter NLT mediates the transport of structurally unrelated
organic anions. The amino acid sequence of NLT exhibits
42% identity to that of a renal multispeci¢c organic anion
transporter OAT1. NLT is the second member of the OAT
family and we propose that NLT be renamed OAT2 (organic
anion transporter 2).
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